Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2018 1
2019 3
2020 3
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J; COAST-X Study Group. Deodhar A, et al. Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5. Lancet. 2020. PMID: 31813637 Clinical Trial.
Environmental Exposures during Puberty: Window of Breast Cancer Risk and Epigenetic Damage.
Natarajan R, Aljaber D, Au D, Thai C, Sanchez A, Nunez A, Resto C, Chavez T, Jankowska MM, Benmarhnia T, Yang JA, Jones V, Tomsic J, McCune JS, Sistrunk C, Doan S, Serrano M, Cardiff RD, Dietze EC, Seewaldt VL. Natarajan R, et al. Among authors: thai c. Int J Environ Res Public Health. 2020 Jan 13;17(2):493. doi: 10.3390/ijerph17020493. Int J Environ Res Public Health. 2020. PMID: 31941024 Free PMC article. Review.
Risk prediction of late-onset Alzheimer's disease implies an oligogenic architecture.
Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, Marcora E, Huang KL, Porter T, Laws SM; Australian Imaging Biomarkers and Lifestyle (AIBL) Study; Sachdev PS, Mather KA, Armstrong NJ, Thalamuthu A, Brodaty H, Yengo L, Yang J, Wray NR, McRae AF, Visscher PM. Zhang Q, et al. Nat Commun. 2020 Sep 23;11(1):4799. doi: 10.1038/s41467-020-18534-1. Nat Commun. 2020. PMID: 32968074 Free PMC article.
Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer's disease.
Roe JM, Vidal-Piñeiro D, Sørensen Ø, Brandmaier AM, Düzel S, Gonzalez HA, Kievit RA, Knights E, Kühn S, Lindenberger U, Mowinckel AM, Nyberg L, Park DC, Pudas S, Rundle MM, Walhovd KB, Fjell AM, Westerhausen R; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Roe JM, et al. Nat Commun. 2021 Feb 1;12(1):721. doi: 10.1038/s41467-021-21057-y. Nat Commun. 2021. PMID: 33526780 Free PMC article.
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume.
Milicic L, Vacher M, Porter T, Doré V, Burnham SC, Bourgeat P, Shishegar R, Doecke J, Armstrong NJ, Tankard R, Maruff P, Masters CL, Rowe CC, Villemagne VL, Laws SM; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Australian Imaging Biomarkers and Lifestyle (AIBL) Study. Milicic L, et al. Geroscience. 2022 Jun;44(3):1807-1823. doi: 10.1007/s11357-022-00558-8. Epub 2022 Apr 21. Geroscience. 2022. PMID: 35445885 Free PMC article.
Author Correction: Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer's disease.
Roe JM, Vidal-Piñeiro D, Sørensen Ø, Brandmaier AM, Düzel S, Gonzalez HA, Kievit RA, Knights E, Kühn S, Lindenberger U, Mowinckel AM, Nyberg L, Park DC, Pudas S, Rundle MM, Walhovd KB, Fjell AM, Westerhausen R; Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing. Roe JM, et al. Nat Commun. 2022 Feb 7;13(1):834. doi: 10.1038/s41467-022-28514-2. Nat Commun. 2022. PMID: 35132105 Free PMC article. No abstract available.
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y).
Landewé RB, Gensler LS, Poddubnyy D, Rahman P, Hojnik M, Li X, Liu Leage S, Adams D, Carlier H, Van den Bosch F; COAST-Y study group. Landewé RB, et al. Ann Rheum Dis. 2021 Aug;80(8):1022-1030. doi: 10.1136/annrheumdis-2020-219717. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958326 Free PMC article. Clinical Trial.
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM; BLAZE-2 Investigators. Cohen MS, et al. Among authors: thai c. JAMA. 2021 Jul 6;326(1):46-55. doi: 10.1001/jama.2021.8828. JAMA. 2021. PMID: 34081073 Free PMC article. Clinical Trial.
14 results